Mohammad Al-bataineh, DVM, MS, PhD Post-doctoral Scholar Rebecca Hughey Laboratory Renal-Electrolyte Division The Protective Role of MUC1/β-catenin Pathway.

Slides:



Advertisements
Similar presentations
NF  B 9/2002 SFRBM Education Program Emily Ho 1 NF  B – What is it and What’s the deal with radicals? Emily Ho, Ph.D Linus Pauling Institute Scientist.
Advertisements

SIGNALING FROM THE CELL SURFACE TO THE NUCLEUS
Metabolism and Cancer Bob Harris D-3034 Roudebush VA Medical Center Fall 2010.
Role of Muc1 in Acute Kidney Injury Rebecca P Hughey Sandra J Gendler and Cathy S Madsen College of Medicine, Mayo Clinic, Scottsdale, AZ Timothy A Sutton.
34 Cancer.
Mechanisms of Apoptosis/Review Ribozyme Inhibition of Bcl-2 Expression/Summary Sandra A. Gibson Hudson Ph.D.
Jacqueline Ho Division of Pediatric Nephrology Children’s Hospital of Pittsburgh Oct. 9, 2014 SMALL RNAS AND SMALL KIDNEYS.
Bcl-2 family There are three classes of Bcl-2 according to their domains and apoptotic effect: – Anti-apoptotic proteins contain four specific domains.
Roderick Tan Lab of Youhua Liu Departments of Medicine and Pathology October 24, 2013 EXTRACELLULAR SUPEROXIDE DISMUTASE IN KIDNEY DISEASE.
Cell Signaling Lecture 13 and 14. Ligand-activated Notch undergoes 2 cleavages before releasing the transcription factor ADAM10: A disintegrin and Metalloprote.
The Virtual Free Radical School Cell Signaling by Oxidants: Mitogen-Activated Protein Kinases (MAPK) and Activator Protein – 1 (AP-1) Brooke T. Mossman*
Hypoxia Inducible Factor – 1 (HIF-1): A High Impact Factor Free Radical & Radiation Biology College of Medicine The University of Iowa
Apoptosis (Programmed Cell Death). Apoptosis vs Necrosis Level of stress, change in environment stress apoptosisnecrosis.
1. MECHANISM OF SUPEROXIDE- MEDIATED DAMAGE RELEVANCE TO MITOCHONDRIAL AGING I.B.Afanas’ev Vitamin Research Institute, Moscow, Russia.
Yan Wu, Xiangru Lu, Fuli Xiang, and Qingping Feng
1. p53 Structure, Function and Therapeutic Applications Provider: Dr.Davood Nourabadi(PhD,medical physiology) mdphysiology.persianblog.ir.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Death and Rescue Regulation of cardiac myocyte cell death Lin GH.
David Gius, M.D., Ph.D. Professor, Departments of Cancer Biology, Pediatrics, and Radiation Oncology Vanderbilt University School of Medicine Sirtuin 3:
The Response of Tumor Cells to Stress and Chemotherapy The Role of PKC Etta Livneh Faculty of Health Sciences.
Therapeutic miRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model Janaiah Kota,1 Raghu R. Chivukula,2 Kathryn A. O’Donnell,3,4 Erik A.
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer Switu Patel.
Potential therapeutic target & predictive biomarker Oncogenic IGFBP2 Sonya Song ( 宋韦 ) Beijing Shijitan Hospital Department of Oncology The Capital Medical.
Smad3-dependent nuclear translocation of B-catenin is required for TGF-B1-induced proliferation of bone marrow- derivced adult human mesenchymal stem cells.
Wnt/β-catenin Signaling Pathway Prospective Target for Cancer Treatment Emelia E Conte 1, Jun Yin 2, Mei Zhang 2 Western Blot Introduction.
Purposes Of Apoptosis Eliminate cells not needed by organism During development: sculpting, remove excess neurons Adult –Maintain tissue size –Eliminate.
Negative regulation of cell cycle by intracellular signals Checkpoint p53 detects DNA damage & activates p21 p21 inhibits cdk2-cyclinA Intracellular Regulation.
SIRT3, the Anti-aging Major Mitochondrial Deacetylase, Is Important for Preventing Pulmonary Fibrosis Renea Jablonski, MD Kamp Lab November 14, 2015.
Cell death vs Cell life. Characteristic morphologic features of apoptosis Extr signal Intr signal nucleus DNA fragmentation (formation of nucleosomal.
Bmi-1 in Cancer Cancer genetics 2012/04/ 전종철
Orkhon Tsogtbaatar, ID: April 18, 2012
Mitochondrial Retrograde Signaling Mediated by UCP2 Inhibits Cancer Cell Proliferation and Tumorigenesis 석사 1 학기 Tran Phuong Thao.
Contribute to Oxidant Stress and
Targeting signal transduction
Integration of cell death responses
Cellular and Molecular Mechanisms of Liver Injury
Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Cellular and Molecular Mechanisms of Liver Injury
Notch1 and its role in pre-T-cell acute lymphoblastic leukemia (T-ALL)
Figure 1 A schematic representation of the HER2 signalling pathway
Volume 82, Issue 8, Pages (October 2012)
Volume 120, Issue 1, Pages (January 2001)
Mechanisms of apoptosis and growth arrest by isothiocyanates.
PK-M2 Makes Cells Sweeter on HIF1
Primary proximal tubule injury leads to epithelial cell cycle arrest, fibrosis, vascular rarefaction, and glomerulosclerosis  Joseph V. Bonventre  Kidney.
Regulator of the apoptotic pathway
Selective estrogen receptor modulation
BMP Receptor 1a and Juvenile Polyposis Syndrome
Apoptosis-targeted therapies for cancer
Keratinocyte Apoptosis in Epidermal Development and Disease
Volume 82, Issue 9, Pages (November 2012)
SOX4 Promotes Proliferative Signals by Regulating Glycolysis through AKT Activation in Melanoma Cells  Wei Dai, Xinyuan Xu, Shuli Li, Jingjing Ma, Qiong.
Autophagy in proximal tubules protects against acute kidney injury
Apoptosis and acute kidney injury
CDK Inhibitors: Cell Cycle Regulators and Beyond
Trop‐2 can bind to IGF‐1 and interfere with IGF‐1R signalling.
Apoptosis-targeted therapies for cancer
Volume 82, Issue 8, Pages (October 2012)
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Acute renal failure: From renal physiology to the renal transcriptome
MYC on the Path to Cancer
Volume 76, Issue 5, Pages (September 2009)
PK-M2 Makes Cells Sweeter on HIF1
Schematic representation of signaling pathways modulated by PKD1 in cancer. Schematic representation of signaling pathways modulated by PKD1 in cancer.
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
Tenets of PTEN Tumor Suppression
UPR and cross-talk between apoptosis and metabolism.
Targeting cyclooxygenase-2 in human neoplasia
Presentation transcript:

Mohammad Al-bataineh, DVM, MS, PhD Post-doctoral Scholar Rebecca Hughey Laboratory Renal-Electrolyte Division The Protective Role of MUC1/β-catenin Pathway in Acute Kidney Injury ​

N C Autocatalytic cleavage within SEA module membrane Near perfect tandem repeats N-linked glycans O-linked glycans MUC1 is a transmembrane glycoprotein with an extracellular mucin-like domain that yields protection from pathogens MUC1 overexpression in tumors is a bad prognosis for the patient MUC1 expression in tumor cell lines:  Pro-survival and anti-apoptotic activities  Modulates transcriptional activities after nuclear targeting Highly conserved across species exhibits multiple sites for protein docking and phosphorylation involved in signal transduction (e.g., HIF1 , GSK3β, β-catenin) MUC1 in the kidney:  Apical expression on all polarized epithelia during development  Found in the DCT and CD in adult kidneys  Found in the PT during development and after injury

Muc1 protein - immunblotting Muc1 is induced during ischemia-reperfusion injury (IRI) C57BL/6 MICE 19 min ischemia N=3-5 mice T= 0-72 h Kidney cortex Muc1 is targeted to the nucleus during IRI (4 h recovery)

Kidney function and morphology are protected by Muc1 during IRI C57BL/6Muc1 KO t=0congested n=3 t=24 h5, 5, 5, 55, 5, 5n=3-4 t=72 hrecoveringcalcificationn=5-6 Wu et al., J. Clin. Invest. 117:2847–2859 (2007)

Muc1 enhances the hypoxia-inducible factor-1 (HIF-1) protective pathway during IRI 19 min ischemia t=4 h lactate dehydrogenase A, enolase, pyruvate kinase M2, and pyruvate dehydrogenase kinase 1

The HIF-1 protective pathway is enhanced by the nuclear targeting of Muc1 in a mouse kidney model of IRI

How the  -catenin protective pathway is regulated in kidneys under metabolic stress conditions like IRI? Kidney International (2012) 82, 537–547 Kidney function Kidney morphology

Cancer Res 2005; 65: (22). November 15, 2005 In cancer cell lines:

Hypothesis Muc1 is protective in a mouse kidney model of IRI also through stabilization and transactivation of the  -catenin protective pathway.

Induction of  -catenin during IRI is absent in Muc1 KO mice  -catenin co-IP with MUC1 in Human kidney proximal tubule HK-2 cells

Nuclear targeting of  -catenin during IRI is absent in Muc1 KO mice

Does MUC1 modulate  -catenin activities during IRI ?

Activation of TCF4 during IRI is significantly reduced in Muc1 KO mice

Activation of Akt is significantly reduced during IRI in the absence of Muc1

Induction of survivin during IRI is absent in Muc1 KO mice

SUMMARY Muc1 stabilizes  -catenin, enhances its nuclear translocation, and augments expression of its downstream targets in a mouse model of AKI. Muc1 protects the kidney during IRI through transactivation of the  -catenin protective pathway, as evidenced by: activation of pro-survival factors like activated Akt, survivin, TCF4, and its target cyclin D1 repression of pro-apoptotic factors; such as p53, and cleaved caspase 3 (consistent with decreased apoptosis) What is the specific role and mechanism of  -catenin signaling during kidney injury, recovery and repair? Future studies

University of Pittsburgh Renal-Electrolyte Division Rebecca Hughey Carol L Kinlough (Truschel) Paul Poland Núria M Pastor-Soler Department of Pathology Sheldon I Bastacky Satdarshan (Paul) Monga Sucha Singh Pediatrics Jackie Ho Funding NIH R01 NRSA (F32) NIDDK O’Brien Kidney Center (P30) Mayo Clinic, Scottsdale, AZ Sandra J Gendler and Cathy S Madsen Indiana University, Indianapolis, IN Timothy A Sutton and Henry E Mang Vanderbilt University, Nashville, TN Volker H Haase and Hanako Kobayashi ACKNOWLEDGMENTS